Different patterns of decompensation in patients with alcoholic vs. non-alcoholic liver cirrhosis

Alimentary Pharmacology and Therapeutics

Volumn 35, Issue 12, 2012, Pages 1443-1450

  Wiegand, J ^a   Kuhne M ^a   Pradat, P ^b,c,d   Mossner J ^a   Trepo, C ^b,c,d   Tillmann, H L ^a,e  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b CROIX ROUSSE HOSPITAL   (France)

^c UNIVERSITÉ LYON 1   (France)

^d CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; ASCITES; BACTERIAL PERITONITIS; BLEEDING; BRAIN DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DECOMPENSATED LIVER CIRRHOSIS; DISEASE CLASSIFICATION; FEMALE; HEPATORENAL SYNDROME; HUMAN; JAUNDICE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONALCOHOLIC LIVER CIRRHOSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; VARIX BLEEDING;

AGE FACTORS; AGED; ALCOHOL DRINKING; ASCITES; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84861198111     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2012.05108.x     Document Type: Article

References (42)

1. Sorensen HT, Thulstrup AM, Mellemkjar L, et al,. Long-term survival and cause-specific mortality in patients with cirrhosis of the liver: a nationwide cohort study in Denmark. J Clin Epidemiol 2003; 56: 88-93. (Pubitemid 36183320)
2. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010; 53: 397-417.
3. Runyon BA,. Management of adult patients with ascites due to cirrhosis: an update. Hepatology 2009; 49: 2087-107.
4. Garcia-Tsao G, Bosch J, Groszmann RJ,. Portal hypertension and variceal bleeding-unresolved issues. Summary of an American Association for the study of liver diseases and European Association for the study of the liver single-topic conference. Hepatology 2008; 47: 1764-72. (Pubitemid 351702758)
5. Bruix J, Sherman M,. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-2.
6. Tandon P, Garcia-Tsao G,. Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis 2008; 28: 26-42. (Pubitemid 351326531)
7. D'Amico G, Morabito A, Pagliaro L, Marubini E,. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci 1986; 31: 468-75. (Pubitemid 16085568)
8. Kumar M, Sakhuja P, Kumar A, et al,. Histological subclassification of cirrhosis based on histological-haemodynamic correlation. Aliment Pharmacol Ther 2008; 27: 771-9. (Pubitemid 351490075)
9. Jepsen P, Ott P, Andersen PK, Sorensen HT, Vilstrup H,. Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study. Hepatology 2010; 51: 1675-82.
10. Wiegand J, Van BF, Berg T,. Management of chronic hepatitis B: status and challenges beyond treatment guidelines. Semin Liver Dis 2010; 30: 361-77.
11. Wiese M, Grungreiff K, Guthoff W, Lafrenz M, Oesen U, Porst H,. Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany-a 25-year multicenter study. J Hepatol 2005; 43: 590-8. (Pubitemid 41253225)
12. Yatsuji S, Hashimoto E, Tobari M, Taniai M, Tokushige K, Shiratori K,. Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C. J Gastroenterol Hepatol 2009; 24: 248-54.
13. Ertle J, Dechene A, Sowa JP, et al,. Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis. Int J Cancer 2011; 128: 2436-43.
14. Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ,. Primary biliary cirrhosis. Hepatology 2009; 50: 291-308.
15. Manns MP, Czaja AJ, Gorham JD, et al,. Diagnosis and management of autoimmune hepatitis. Hepatology 2010; 51: 2193-213.
16. Alvarez F, Berg PA, Bianchi FB, et al,. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-38. (Pubitemid 29514229)
17. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R,. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-9.
18. Schuppan D, Afdhal NH,. Liver cirrhosis. Lancet 2008; 371: 838-51. (Pubitemid 351323895)
19. Bell BP, Manos MM, Zaman A, et al,. The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance. Am J Gastroenterol 2008; 103: 2727-36.
20. Meyer C, Rumpf HJ, Hapke U, John U,. Regional differences in the prevalence of high-risk alcohol drinking: secondary analysis of the East-West health survey. Gesundheitswesen 1998; 60: 486-92. (Pubitemid 128532381)
21. Wiegand J, Kaiser T, Lobstein S, et al,. Low prevalence of chronic hepatitis C, but high prevalence of elevated aminotransferases in a cohort of 2026 patients referred for orthopaedic surgery in the eastern part of Germany. Z Gastroenterol 2006; 44: 11-4. (Pubitemid 43189473)
22. Wiegand J, Luz B, Mengelkamp AK, et al,. Autologous blood donor screening indicated a lower prevalence of viral hepatitis in East vs West Germany: epidemiological benefit from established health resources. J Viral Hepat 2009; 16: 743-8.
23. Yuen MF, Tanaka Y, Fong DY, et al,. Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. J Hepatol 2009; 50: 80-8.
24. McMahon BJ,. The natural history of chronic hepatitis B virus infection. Hepatology 2009; 49: S45-55.
25. Hadziyannis SJ,. Natural history of chronic hepatitis B in Euro-Mediterranean and African Countries. J Hepatol 2011; 55: 183-91.
26. Yang YF, Zhao W, Zhong YD, Xia HM, Shen L, Zhang N,. Interferon therapy in chronic hepatitis B reduces progression to cirrhosis and hepatocellular carcinoma: a meta-analysis. J Viral Hepat 2009; 16: 265-71.
27. George SL, Bacon BR, Brunt EM, Mihindukulasuriya KL, Hoffmann J, Di Bisceglie AM,. Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow-up of 150 patients. Hepatology 2009; 49: 729-38.
28. Morgan TR, Ghany MG, Kim HY, et al,. Outcome of sustained virological responders with histologically advanced chronic hepatitis C. Hepatology 2010; 52: 833-44.
29. Chang TT, Lai CL, Kew YS, et al,. Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B. Hepatology 2010; 51: 422-30.
30. Van BF, de Man RA, Wedemeyer H, et al,. Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues. Hepatology 2010; 51: 73-80.
31. Schiff ER, Lee SS, Chao YC, et al,. Long-term treatment with entecavir induces reversal of advanced fibrosis or cirrhosis in patients with chronic hepatitis B. Clin Gastroenterol Hepatol 2011; 9: 274-6.
32. Bell H, Jahnsen J, Kittang E, Raknerud N, Sandvik L,. Long-term prognosis of patients with alcoholic liver cirrhosis: a 15-year follow-up study of 100 Norwegian patients admitted to one unit. Scand J Gastroenterol 2004; 39: 858-63. (Pubitemid 39215457)
33. Sola R, Alvarez MA, Balleste B, et al,. Probability of liver cancer and survival in HCV-related or alcoholic-decompensated cirrhosis. A study of 377 patients. Liver Int 2006; 26: 62-72.
34. Stroffolini T, Cotticelli G, Medda E, et al,. Interaction of alcohol intake and cofactors on the risk of cirrhosis. Liver Int 2010; 30: 867-70.
35. McDonald SA, Hutchinson SJ, Bird SM, et al,. Hospitalization of hepatitis C-diagnosed individuals in Scotland for decompensated cirrhosis: a population-based record-linkage study. Eur J Gastroenterol Hepatol 2010; 22: 49-57.
36. Sanyal A, Poklepovic A, Moyneur E, Barghout V,. Population-based risk factors and resource utilization for HCC: US perspective. Curr Med Res Opin 2010; 26: 2183-91.
37. Toshikuni N, Izumi A, Nishino K, et al,. Comparison of outcomes between patients with alcoholic cirrhosis and those with hepatitis C virus-related cirrhosis. J Gastroenterol Hepatol 2009; 24: 1276-83.
38. Sanyal AJ, Banas C, Sargeant C, et al,. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C. Hepatology 2006; 43: 682-9.
39. Saunders JB, Walters JR, Davies AP, Paton A,. A 20-year prospective study of cirrhosis. Br Med J (Clin Res Ed) 1981; 282: 263-6. (Pubitemid 11188540)
40. Propst A, Propst T, Zangerl G, Ofner D, Judmaier G, Vogel W,. Prognosis and life expectancy in chronic liver disease. Dig Dis Sci. 1995; 40: 1805-15.
41. Fleming KM, Aithal GP, Card TR, West J,. The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study. Aliment Pharmacol Ther 2010; 32: 1343-50.
42. Das K, Das K, Datta S, et al,. Course of disease and survival after onset of decompensation in hepatitis B virus-related cirrhosis. Liver Int 2010; 30: 1033-42.